Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B
10.1128/AAC.50.5.1642-1648.2006
Saved in:
Main Authors: | Lim, S.G., Krastev, Z., Ng, T.M., Mechkov, G., Kotzev, I.A., Chan, S., Mondou, E., Snow, A., Sorbel, J., Rousseau, F. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2011
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/26669 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: Implications for pre-exposure prophylaxis adherence monitoring
by: Monica Gandhi, et al.
Published: (2018) -
Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: Implications for pre-exposure prophylaxis adherence monitoring
by: Monica Gandhi, et al.
Published: (2018) -
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B
by: Lim, S.G., et al.
Published: (2011) -
Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
by: Lim, S.G., et al.
Published: (2011) -
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
by: Avihingsanon A.
Published: (2023)